Isis Subsidiary Receives Grants, Contracts Worth $8.4 Million

Luke Timmerman10/3/08

Isis Pharmaceuticals said today that its diagnostic subsidiary, Ibis Biosciences, was awarded federal grants and contracts worth as much as $8.4 million. The Carlsbad, CA-based company (NASDAQ: ISIS) said its subsidiary got the grants and contracts from the U.S. Department of Agriculture, National Institute of Justice, and other agencies. The company is being asked to help identify flu viruses, other pathogens, and offer improved forensics.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.